Structural analysis of the 11β-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease

被引:22
作者
Zaehner, T [1 ]
Plueshke, V [1 ]
Frey, BM [1 ]
Frey, FJ [1 ]
Ferrari, P [1 ]
机构
[1] Univ Bern, Inselspital, Div Nephrol & Hypertens, CH-3010 Bern, Switzerland
关键词
hypertension; genetics; single nucleotide polymorphism; progressive renal failure; mutation; salt dependency;
D O I
10.1046/j.1523-1755.2000.00303.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta HSD2) gene cause a rare form of low-renin hypertension leading to end-stage renal disease (ESRD) in some affected subjects. To date, no search for mutations in the HSD11B2 gene was performed in a large population to obtain an estimate its prevalence. Methods. The HSD11B2 gene was analyzed in 587 subjects, including 260 ESRD patients (either dialysis or transplanted) for mutations in the exons 2 through 5 and corresponding intronic regions by polymerase chain reaction (PCR) using appropriate overlapping primers, gel analysis by single strand conformational polymorphism (SSCP), and sequencing of identified migration variants. Results. The prevalence of single-nucleotide polymorphisms (SNPs) in ESRD patients and controls was 26%. The following genetic variants were found among all subjects investigated: exon 2 T442G (Leu(148)/Val, N = 70) and C470A (Thr(156)/Thr, N = 67), exon 3 G534A (Glu(178)/Glu, N = 69), and exon 5 C1274T (Asp(388)/Asp, N = 2). Four SNPs were identified in intron 4 only. In the control population, the prevalence of the variants Leu(148) and Thr(156) was 14% each. Glu(178) was 11%, while no variants were found in exon 5. In ESRD patients, the prevalence of the variant Leu(148) was 9%, and Thr(156) was 8%. Glu(178) was 13%, while the Asp(388) variant was 0.7%. In patients with a short duration between the time of diagnosis of the renal disease and the onset of ESRD, the prevalence of the Leu(148) and Glu(178) variants was higher than in subjects with slowly progressing renal disease. The 11 beta HSD2 activity of all of these SNPs is predictably unaltered. Conclusions. There is a high prevalence of SNPs of the HSD11B2 gene, without causing exonic mutations generating a 11 beta HSD2 enzyme with altered activity. Based on statistical analyses, the frequency of homozygosity for mutated alleles of the HSD11B2 gene can be derived as <1/250,000 when a Caucasian population is considered.
引用
收藏
页码:1413 / 1419
页数:7
相关论文
共 41 条
[1]  
AGARWAL AK, 1994, J BIOL CHEM, V269, P25959
[2]   GENE STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN HSD11K GENE ENCODING THE KIDNEY (TYPE-2) ISOZYME OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
AGARWAL, AK ;
ROGERSON, FM ;
MUNE, T ;
WHITE, PC .
GENOMICS, 1995, 29 (01) :195-199
[3]   CLONING AND TISSUE DISTRIBUTION OF THE HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2 ENZYME [J].
ALBISTON, AL ;
OBEYESEKERE, VR ;
SMITH, RE ;
KROZOWSKI, ZS .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 105 (02) :R11-R17
[4]   Functional characterization of transcriptional regulatory elements in the upstream region and intron 1 of the human S6 ribosomal protein gene [J].
Antoine, M ;
Kiefer, P .
BIOCHEMICAL JOURNAL, 1998, 336 :327-335
[5]   Structural analysis and evaluation of the 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) gene in human essential hypertension [J].
Brand, E ;
Kato, N ;
Chatelain, N ;
Krozowski, ZS ;
Jeunemaitre, X ;
Corvol, P ;
Plouin, PF ;
Cambien, F ;
Pascoe, L ;
Soubrier, F .
JOURNAL OF HYPERTENSION, 1998, 16 (11) :1627-1633
[6]   PROGRESSION OF RENAL-INSUFFICIENCY - ROLE OF BLOOD-PRESSURE [J].
BRAZY, PC ;
STEAD, WW ;
FITZWILLIAM, JF .
KIDNEY INTERNATIONAL, 1989, 35 (02) :670-674
[7]   Prevalence of hypertension in 1,795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohort [J].
Buckalew, VM ;
Berg, RL ;
Wang, SR ;
Porush, JG ;
Rauch, S ;
Schulman, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (06) :811-821
[8]   Characterization of single-nucleotide polymorphisms in coding regions of human genes [J].
Cargill, M ;
Altshuler, D ;
Ireland, J ;
Sklar, P ;
Ardlie, K ;
Patil, N ;
Lane, CR ;
Lim, EP ;
Kalyanaraman, N ;
Nemesh, J ;
Ziaugra, L ;
Friedland, L ;
Rolfe, A ;
Warrington, J ;
Lipshutz, R ;
Daley, GQ ;
Lander, ES .
NATURE GENETICS, 1999, 22 (03) :231-238
[9]   Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements [J].
Clyne, CD ;
Zhang, Y ;
Slutsker, L ;
Mathis, JM ;
White, PC ;
Rainey, WE .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (05) :638-649
[10]   Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2 [J].
Davies, E ;
Holloway, CD ;
Ingram, MC ;
Inglis, GC ;
Friel, EC ;
Morrison, C ;
Anderson, NH ;
Fraser, R ;
Connell, JMC .
HYPERTENSION, 1999, 33 (02) :703-707